Cancer immunology and immunotherapy

Label

• Cancer immunology and immunotherapy (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi

• Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery. (Articolo in rivista) (Prodotto della ricerca)
• Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression (Articolo in rivista) (Prodotto della ricerca)
• Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and (Articolo in rivista) (Prodotto della ricerca)
• Immunological and biological changes during Ipilimumab treatment and their potential correlation with clinical response and survival: single-centre experience from an expanded access programme. (Articolo in rivista) (Prodotto della ricerca)
• The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back. (Articolo in rivista) (Prodotto della ricerca)
• Influence of low- dose beta interferon on natural killer activity in breast cancer patients subjected to chemotherapy. (Articolo in rivista) (Prodotto della ricerca)

Alternative label

• Cancer immunology and immunotherapy. (literal)
• Cancer immunol. immunother. (literal)
• Cancer immunology, immunotherapy (Print) (literal)
• CII. Cancer immunology and immunotherapy (literal)

Language

• eng (literal)

Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#issn

• 0340-7004 (literal)

Preferred label

• Cancer immunology and immunotherapy (literal)

Publisher

• Springer Berlin : DEU (literal)

Incoming links:

Rivista

• Simultaneous measurement of sCEA and TIMP1 serum levels for use as pre-invasive to invasive markers of colorectal cancer. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
• The Significance of an increase in soluble interleukin- 2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 o TH2 and back. (Articolo in rivista) (Prodotto della ricerca)
• Disregulation in TH1 and TH2 subsets of CD4+ T cells in peripheral blood of colorectal cancer patients and involvement in cancer establishment and progression (Articolo in rivista) (Prodotto della ricerca)
• Progression mechanisms in colon cancer: soluble interleukin2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and (Articolo in rivista) (Prodotto della ricerca)
• Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery. (Articolo in rivista) (Prodotto della ricerca)
• Influence of low- dose beta interferon on natural killer activity in breast cancer patients subjected to chemotherapy. (Articolo in rivista) (Prodotto della ricerca)
• Immunological and biological changes during Ipilimumab treatment and their potential correlation with clinical response and survival: single-centre experience from an expanded access programme. (Articolo in rivista) (Prodotto della ricerca)